Baikang Biological Group Holdings Limited Sustainability Profile
Baikang Biological Group Holdings Limited, often referred to as Baikang, is a prominent player in the biotechnology sector, headquartered in China (CN). Established in 2001, the company has made significant strides in the development and production of innovative biological products, primarily focusing on health and wellness solutions. With a strong operational presence across various regions in Asia, Baikang is renowned for its unique offerings in the fields of pharmaceuticals and nutritional supplements. The company’s commitment to quality and research has positioned it as a leader in the industry, achieving notable milestones such as the introduction of cutting-edge biopharmaceuticals that cater to evolving consumer needs. Baikang's dedication to excellence and innovation has solidified its market position, making it a trusted name in the biotechnology landscape.
DitchCarbon Score
How does Baikang Biological Group Holdings Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Baikang Biological Group Holdings Limited's score of 20 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Baikang Biological Group Holdings Limited's reported carbon emissions
Baikang Biological Group Holdings Limited, headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Baikang Biological Group Holdings Limited is approaching climate commitments within the industry context. The absence of reported emissions and targets may reflect a need for enhanced transparency and accountability in their environmental strategies.
How Carbon Intensive is Baikang Biological Group Holdings Limited's Industry?
How Carbon Intensive is Baikang Biological Group Holdings Limited's Location?
Baikang Biological Group Holdings Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Baikang Biological Group Holdings Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
